Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aptatek Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Aptatek Biosciences

Aptatek Biosciences

Aptatek develops portable disease management devices using proprietary technology for improved patient wellness.

HQ
Princeton, NJ, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize chronic disease management, Aptatek Biosciences develops portable, home-based monitoring devices aimed at improving patient compliance and quality of life. The company’s initial focus is on Phenylketonuria (PKU), a condition requiring lifelong monitoring of phenylalanine levels. Utilizing proprietary aptamer technology, Aptatek offers a smartphone-based test platform that allows patients to monitor their condition from home, eliminating the need for hospital visits or mailing blood samples.

Aptatek has garnered significant recognition, including the FDA's Breakthrough Device designation for its PKU monitoring test. The company's leadership includes experts in biotechnology and medical device development, supported by a network of investors committed to advancing healthcare innovation. Aptatek's impact lies in its potential to transform chronic disease management, making it more accessible and convenient for patients worldwide.

Aptatek Biosciences - Similar Companies

MobileMedTek logo

MobileMedTek

Dawatek logo

Dawatek

Aptah logo

Aptah

aptah-bio.com

Pocket Clinic logo

Pocket Clinic

pocketclinic.life

Luminostics logo

Luminostics

APT Pharmaceuticals logo

APT Pharmaceuticals

Aptitude Medical Systems logo

Aptitude Medical Systems

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Aptinyx logo

Aptinyx

aptinyx.com

Test Anywhere Technology logo

Test Anywhere Technology

Apex Neuro logo

Apex Neuro

Nano Mobile Healthcare logo

Nano Mobile Healthcare

Aperture Bio logo

Aperture Bio

aperture.bio

aptihealth logo

aptihealth

aptihealth.com

YourBio Health logo

YourBio Health

yourbiohealth.com

Aptatek Biosciences - Quick Facts

Who are Aptatek Biosciences' competitors?

Companies similar to Aptatek Biosciences include MobileMedTek, Dawatek, Aptah and Pocket Clinic.

When was Aptatek Biosciences founded?

Aptatek Biosciences was founded in 2008.

Where is Aptatek Biosciences' headquarters located?

Aptatek Biosciences' headquarters is located in Princeton, NJ, US.

When was Aptatek Biosciences' last funding round?

Aptatek Biosciences' most recent funding round was for $4M (USD) in March 2022.

How much has Aptatek Biosciences raised to-date?

As of Mar 16, 2022, Aptatek Biosciences has raised a total of $4M (USD).

How many employees does Aptatek Biosciences have?

Aptatek Biosciences has 3 employees as of Feb 4, 2024.

Aptatek Biosciences - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Software
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified